Cargando…

Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated Colitis

Purpose: While the occurrence of colitis during immune checkpoint inhibitor (ICI) treatment is recognized as a sign of robust immune activation and correlates with better oncological outcomes, the long-term impact of ICI-mediated colitis on the colonic mucosa has not been studied. We thus aim to des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machado, Antonio Pizuorno, Shatila, Malek, De Toni, Enrico N., Török, Helga-Paula, Philpott, Jessica, Zhao, Dan, Zhou, Yan, Varatharajalu, Krishnavathana, Shafi, Mehnaz A., Zhang, Hao Chi, Thomas, Anusha S., Wang, Yinghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539391/ https://www.ncbi.nlm.nih.gov/pubmed/37779873 http://dx.doi.org/10.7150/jca.86635

Ejemplares similares

Obesity Measured via Body Mass Index May Be Associated with Increased Incidence but Not Worse Outcomes of Immune-Mediated Diarrhea and Colitis
por: Kono, Miho, et al.
Publicado: (2023)

The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review
por: Machado, Antonio Pizuorno, et al.
Publicado: (2023)

Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer
por: Liu, Cynthia, et al.
Publicado: (2023)

Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors
por: Vasavada, Shaleen, et al.
Publicado: (2022)

Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors
por: Panneerselvam, Kavea, et al.
Publicado: (2022)

Clinical Features and Management of Acute and Chronic Radiation-Induced Colitis and Proctopathy
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2023)

Diarrhea and colitis related to immune checkpoint inhibitor and BRAF/MEK inhibitor therapy
por: Kuang, Andrew G., et al.
Publicado: (2023)

Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection
por: Shatila, Malek, et al.
Publicado: (2022)

Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
por: Zhang, Hao Chi, et al.
Publicado: (2019)

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2019)

Diffuse Metastatic Melanoma in the GI Lumen Following Immune Checkpoint Inhibitor Colitis Treatment
por: Sperling, Gabriel, et al.
Publicado: (2022)

Cap-fitted endoscopic mucosal resection of ≥ 20 mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate
por: Raju, Gottumukkala S., et al.
Publicado: (2020)

Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2018)

Severe Inflammatory Colitis Related to Encorafenib and Binimetinib following Immune Checkpoint Inhibitor Therapy
por: Issac, Aaron G., et al.
Publicado: (2022)

Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas
por: Chen, Jian, et al.
Publicado: (2016)

Checkpoint blockade therapy for functioning pituitary adenomas
por: Lorrey, Selena J., et al.
Publicado: (2020)

Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2019)

Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis
por: Khan, Jaffar, et al.
Publicado: (2021)

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2018)

Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2019)

Gut microbiome and checkpoint inhibitor colitis
por: Sehgal, Kanika, et al.
Publicado: (2021)

Checkpoint Inhibitor-Induced Colitis: An Update
por: Losurdo, Giuseppe, et al.
Publicado: (2023)

Colonic diverticulosis is not a risk factor for colonic adenoma
por: Hong, Wandong, et al.
Publicado: (2018)

Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
por: Wang, Yinghong, et al.
Publicado: (2018)

Hidden Adenoma in a Colon Diverticulum
por: Hashimoto, Yu, et al.
Publicado: (2020)

Colon adenoma features and their impact on risk of future advanced adenomas and colorectal cancer
por: Calderwood, Audrey H, et al.
Publicado: (2016)

Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018)

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
por: Westdorp, Harm, et al.
Publicado: (2021)

Refractory Checkpoint Inhibitor Colitis Responsive to Ustekinumab
por: Perez Del Nogal, Genesis, et al.
Publicado: (2022)

Incidence of immune checkpoint inhibitor–mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score–matched retrospective study
por: Sleiman, Joseph, et al.
Publicado: (2021)

Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis
por: Fredrick, Thomas W, et al.
Publicado: (2022)

Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis
por: Zou, Fangwen, et al.
Publicado: (2021)

The food additive EDTA aggravates colitis and colon carcinogenesis in mouse models
por: Evstatiev, Rayko, et al.
Publicado: (2021)

Functional Toll-Like Receptor (TLR)2 polymorphisms in the susceptibility to inflammatory bowel disease
por: Török, Helga Paula, et al.
Publicado: (2017)

Fecal Microbiota and Associated Volatile Organic Compounds Distinguishing No-Adenoma from High-Risk Colon Adenoma Adults
por: Katsaounou, Kyriaki, et al.
Publicado: (2023)

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2019)

Cell-surface markers for colon adenoma and adenocarcinoma
por: Sewda, Kamini, et al.
Publicado: (2016)

Prevalence and characteristics of colonic adenoma in mainland China
por: Hong, Wandong, et al.
Publicado: (2018)

Association of Colonic Diverticula with Colorectal Adenomas and Cancer
por: Viscido, Angelo, et al.
Publicado: (2021)

Lectins, Colitis and Colon Cancer
por: Rhodes, Jonathan M
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_g3g2ofc8cbjk97h5bohn5657rc